PW Medtech Releases 2026 Interim Report, Promotes Shift to E-Communication

Bulletin Express
Sep 21

PW Medtech Group Limited announced on 22 September 2026 that its 2026 Interim Report is now available in both English and Chinese on the company’s website (www.pwmedtech.com) and on the Hong Kong Stock Exchange website (www.hkexnews.hk).

Registered shareholders who have previously elected to receive printed materials will receive hard copies by post. Others are encouraged to access the online version to expedite information flow and reduce paper consumption.

Shareholders encountering difficulties with email notifications or web access, or those who prefer printed documents, can request hard copies free of charge by completing and returning the enclosed Reply Form to Tricor Investor Services Limited, the company’s Hong Kong branch share registrar, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing is-ecom@vistra.com.

The company underscores the importance of maintaining a valid email address on file. Without a functioning address, shareholders will receive only hard-copy notices and actionable corporate communications until an updated address is provided.

Enquiries can be directed to Tricor’s hotline at (852) 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays).

The notice, issued under the name of Chairman and Chief Executive Officer Ms. Yue’e Zhang, reiterates that all future corporate communications—including annual and interim reports, meeting notices, listing documents, circulars and proxy forms—will be distributed according to each shareholder’s selected format.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10